GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

Company number 04173789

Date	Type	Description	View / Download
20 Oct 2018	GAZ2	Final Gazette dissolved following liquidation	(1 page)
20 Jul 2018	AM23	Notice of move from Administration to Dissolution	(15 pages)
03 Jul 2018	AM01	Appointment of an administrator
03 Jul 2018	AM15	Notice of resignation of an administrator	(14 pages)
15 Mar 2018	AM10	Administrator's progress report	(18 pages)
05 Oct 2017	AM06	Notice of deemed approval of proposals	(3 pages)
05 Oct 2017	AM03	Statement of administrator's proposal	(36 pages)
27 Sep 2017	AM02	Statement of affairs with form AM02SOA/AM02SOC	(16 pages)
12 Sep 2017	AD01	Registered office address changed from 45B Western Avenue Milton Park Abingdon Oxfordshire OX14 4RU to Rsm Restructuring Advisory Llp 3 Hardman Street Manchester M3 3HF on 12 September 2017	(2 pages)
11 Sep 2017	AM01	Appointment of an administrator	(4 pages)
28 Apr 2017	AP01	Appointment of Mr James Anthony Otter as a director on 27 April 2017	(2 pages)
31 Mar 2017	AA	Full accounts made up to 30 June 2016	(24 pages)
08 Mar 2017	CS01	Confirmation statement made on 8 March 2017 with updates	(15 pages)
20 Feb 2017	SH01	Statement of capital following an allotment of shares on 19 January 2017 GBP 1,005.5752	(4 pages)
13 Feb 2017	TM01	Termination of appointment of Bryan Geoffrey Morton as a director on 11 February 2017	(1 page)
13 Feb 2017	TM01	Termination of appointment of Medinnovate Ltd as a director on 11 February 2017	(1 page)
13 Feb 2017	AP01	Appointment of Mr Fraser Andrew Skirrow as a director on 11 February 2017	(2 pages)
01 Feb 2017	MR01	Registration of charge 041737890004, created on 20 January 2017	(21 pages)
27 Jan 2017	CS01	Confirmation statement made on 14 January 2017 with updates	(17 pages)
19 Jan 2017	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(79 pages)
07 Dec 2016	TM01	Termination of appointment of Mark Carnegie-Brown as a director on 25 November 2016	(1 page)
12 Aug 2016	AA01	Previous accounting period shortened from 31 December 2016 to 30 June 2016	(1 page)
19 May 2016	AA	Full accounts made up to 31 December 2015	(22 pages)
12 Feb 2016	AR01	Annual return made up to 14 January 2016 with full list of shareholders Statement of capital on 2016-02-12 GBP 980.2802	(15 pages)
01 Jun 2015	AA	Full accounts made up to 31 December 2014	(24 pages)

• 1
• 2
• 3
• 4
• 5
• 6
• 7

Next